PT951284E - Derivados de feniletilamina - Google Patents

Derivados de feniletilamina

Info

Publication number
PT951284E
PT951284E PT97952645T PT97952645T PT951284E PT 951284 E PT951284 E PT 951284E PT 97952645 T PT97952645 T PT 97952645T PT 97952645 T PT97952645 T PT 97952645T PT 951284 E PT951284 E PT 951284E
Authority
PT
Portugal
Prior art keywords
dementia
alkyl
hydrogen
compounds
directed
Prior art date
Application number
PT97952645T
Other languages
English (en)
Inventor
Michael Chorev
Tamar Goren
Yacov Herzig
Jeffrey Sterling
Marta Weinstock-Rosin
Moussa B H Youdim
Original Assignee
Yissum Res Dev Co
Technion Res & Dev Foundation
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11985296A external-priority patent/IL119852A0/xx
Priority claimed from IL12050997A external-priority patent/IL120509A0/xx
Application filed by Yissum Res Dev Co, Technion Res & Dev Foundation, Teva Pharma filed Critical Yissum Res Dev Co
Publication of PT951284E publication Critical patent/PT951284E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97952645T 1996-12-18 1997-12-18 Derivados de feniletilamina PT951284E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11985296A IL119852A0 (en) 1996-12-18 1996-12-18 Phenylethylamine derivatives
IL12050997A IL120509A0 (en) 1997-03-24 1997-03-24 Phenylethylamine derivatives

Publications (1)

Publication Number Publication Date
PT951284E true PT951284E (pt) 2003-12-31

Family

ID=26323337

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97952645T PT951284E (pt) 1996-12-18 1997-12-18 Derivados de feniletilamina

Country Status (12)

Country Link
EP (1) EP0951284B1 (pt)
JP (1) JP4116085B2 (pt)
AT (1) ATE251456T1 (pt)
AU (1) AU5620998A (pt)
CA (1) CA2275371C (pt)
DE (1) DE69725467T2 (pt)
DK (1) DK0951284T3 (pt)
ES (1) ES2208967T3 (pt)
HK (1) HK1022838A1 (pt)
HU (1) HU226526B1 (pt)
PT (1) PT951284E (pt)
WO (1) WO1998026775A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US8097608B2 (en) 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
EP1686973A4 (en) * 2003-11-25 2009-03-25 Technion Res & Dev Foundation COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES
BRPI0605940A2 (pt) * 2005-01-13 2009-05-26 Hoffmann La Roche sìntese de aminas dissubstituìdas úteis em uma etapa
WO2006091836A1 (en) 2005-02-24 2006-08-31 Teva Pharmaceutical Industries, Ltd. Formulations of ladostigil tartrate
CA2634166C (en) 2005-12-09 2016-03-29 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
TW200744576A (en) 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
CA3229907A1 (en) * 2021-08-23 2023-03-02 Nicholas COZZI Deuterated empathogens
WO2023028092A2 (en) * 2021-08-23 2023-03-02 Alexander Shulgin Research Institute Fluorinated empathogens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6408165A (pt) * 1964-07-17 1966-01-18
US3507962A (en) * 1969-05-09 1970-04-21 Thompson Chem Co Hayward Controlling leafminer insects with selected carbamate insecticides,including 3,5-dimethyl-4-dimethylamino-methyl phenyl-n-methylcarbamate
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0951284B1 (en) 2003-10-08
HUP0003180A3 (en) 2002-11-28
HU226526B1 (en) 2009-03-30
DK0951284T3 (da) 2004-02-16
HK1022838A1 (en) 2000-08-25
CA2275371C (en) 2008-07-29
WO1998026775A1 (en) 1998-06-25
ATE251456T1 (de) 2003-10-15
DE69725467T2 (de) 2004-07-22
CA2275371A1 (en) 1998-06-25
EP0951284A1 (en) 1999-10-27
AU5620998A (en) 1998-07-15
DE69725467D1 (de) 2003-11-13
EP0951284A4 (en) 2002-03-20
JP2001506655A (ja) 2001-05-22
HUP0003180A2 (hu) 2001-01-29
ES2208967T3 (es) 2004-06-16
JP4116085B2 (ja) 2008-07-09

Similar Documents

Publication Publication Date Title
DK0966435T3 (da) Aminoindanderivater
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
SE0104340D0 (sv) New compounds
DK1319651T3 (da) 2-aminopropan-1,3-diolforbindelser, medicinsk anvendelse deraf og mellemprodukter til syntese af disse
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
BG105781A (en) Piperidine, tetrahydropyridine and piperazine derivatives, their preparartion and use
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
NZ338016A (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
SE9601110D0 (sv) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
PT951284E (pt) Derivados de feniletilamina
NO307464B1 (no) Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter
HUP0001093A2 (hu) 5-HT2A-antagonista oxazolidinon-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
KR970706826A (ko) 포스포디에스테라제 IV 억제제로서의 디아제피노-인돌(Diazepino-Indoles as Phosphodiesterase Ⅳ Inhibitors)
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
NZ536524A (en) Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
DE69825879D1 (de) Pharmazeutische zusammensetzungen welche aryl-substituierte olefinische amin-verbindungen enthalten
ATE157873T1 (de) Verwendung von benzodiazepinverbindungen zur herstellung eines arzneimittels gegen mit excitatorischen aminosäuren verbundene zentralnervensystem-störungen
DE69327077T2 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
DE59308331D1 (de) Verfahren zur Herstellung von 1-unsubstituierten 3-Aminopyrrolen